APR 21, 2021 10:00 AM PDT

Putting Serological SARS-CoV-2 Testing into Context

Sponsored by: Bio-Rad Laboratories
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Staff Scientist, Vitalant Research Institute
    Biography
      Eduard Grebe is a staff scientist at Vitalant Research Institute with substantial experience in infectious diseases epidemiology and a particular focus on HIV incidence. As the principal analyst for the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) he led a number of impactful studies, including the first demonstration that high dynamic range diagnostic assays can be used to identify recent HIV infections for population-level incidence estimation. He serves on the World Health Organization's Working Group on HIV Incidence Measurement and Data Use, led the assessment of first-time blood donor incidence after a change in donor eligibility for the US FDA's Transfusion Transmissible Infections Monitoring System and has contributed to donor epidemiological studies in the United States, Brazil and South Africa. He has helped develop tools and methods for estimating HIV incidence, for characterizing tests for recent HIV infection, an infection dating algorithm and tools for estimating residual transfusion transmission risk in blood donors. He leads the analysis for a major evaluation of SARS-CoV-2 serologic assays.
    • Medical Director Research and Clinical Trials, TriCore Research Institute
      Biography
        Dr. Veronica Luzzi is the medical director for clinical trials and research at TriCore Research Institute, Albuquerque, New Mexico. She obtained a Ph.D. in Biology at the University of California, Irvine, in March 2000 the Department of Physiology and Biophysics, and completed her training in Clinical Chemistry in the Department of Pathology and Laboratory Medicine at Washington University in St. Louis, Missouri in 2003. Dr. Luzzi is a diplomat of the American Board in Clinical Chemistry and is a Fellow of the Academy in Clinical Biochemistry.
        Dr. Luzzi's experience in the clinical laboratory has been diverse. Shortly after her postdoctoral training, at Washington University in St. Louis, she became the CLIA medical director of the Core Lab for Clinical Studies. In that role, she successfully merged a few small research laboratories into a single entity, delivered projects to pharmaceutical partners, and initiated studies with in-vitro diagnostic companies. During her tenure at Henry Ford Hospital, in Detroit, Michigan, she developed and maintained a Clinical Chemistry curriculum for the Pathology residency program and sponsored several residents to publish their work. She also contributed to obtaining ISO 15189 certification and became well versed on the ISO standards. More recently, at Providence Health & Services in Oregon, Dr. Luzzi had multiple roles. She was the CLIA medical director of the Core Laboratory and successfully helped create and expand the Toxicology department, designed a team structure to support the rapid response laboratories using centralized expertise, identified quality gaps in the operations and corrected them, and worked with clinical experts to modify ordering practices and promote test utilization.
        Currently, her central role focuses in identifying, delivering, and participating in clinical device trials and related opportunities that directly align with TriCore's strategic needs. She is responsible for providing a centralized infrastructure to promote quality research, ensure fiscal and regulatory compliance, encourage collaborations, and expand clinical device trials and related offerings. Among other activities, she implements solutions to meet quality standards for all stages of analytical testing, writes analytical procedures, and teaches different aspects of clinical chemistry to laboratory scientists, residents, and fellows.
        She and her family are enjoying the many bike and pedestrian trails and the wonderful state and national monuments in the Albuquerque and Santa Fe areas. She loves New Mexican cuisine and hopes one day she can master the diversity of dishes and delicious recipes of the area.



      • Assistant Professor, the University of Pittsburgh Medical Center, Department of Pathology
        Biography
          Dr. Sarah Wheeler is an Assistant Professor at the University of Pittsburgh, Department of Pathology, Medical Director of Clinical Chemistry at Children's Hospital of Pittsburgh of UPMC, Medical Director of the Automated Testing Laboratory at Mercy Hospital, and Associate Medical Director of Clinical Immunopathology at UPMC. Her research interests include infectious disease serology screening assays (SARS-CoV-2, HIV, syphilis, lyme, hepatitis), rapid point of care diagnostics, and appropriate serology testing in children with immune dysregulation. Dr. Wheeler completed her doctoral work at the University of Pittsburgh in cellular and molecular pathology. She completed a combined basic research and clinical post-doctoral fellowship at the University of Pittsburgh in metastatic breast cancer and clinical chemistry respectively. Since her post-doctoral fellowship Dr. Wheeler has worked in both industry and academic medical centers, combining research and clinical duties.

        Abstract
        Date:  April 21, 2021
        Time: 10:00am (PDT),  1:00pm (EDT)
         
        Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar, our speakers will present on how they have used serological testing for SARS-CoV-2 in their clinical labs and the studies they have performed to further validate their use in clinical decision making.
         
        Learning Objectives
        • Demonstrate the current applications of SARS-CoV-2 serology
        • Discuss where SARS-CoV-2 testing can fit into vaccination campaigns
        • Analyze the changes in SARS-CoV-2 antibody profiles over time in naturally infected patients
        • Illustrate how current serological assays correlate to neutralizing antibody assays
         
         
        Webinars will be available for unlimited on-demand viewing after live event.
         
        LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

        Show Resources
        You May Also Like
        MAY 11, 2021 10:00 AM PDT
        C.E. CREDITS
        MAY 11, 2021 10:00 AM PDT
        Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
        JUN 09, 2021 7:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        C.E. CREDITS
        JUN 09, 2021 7:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
        DEC 02, 2020 8:00 AM PST
        C.E. CREDITS
        DEC 02, 2020 8:00 AM PST
        DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
        APR 01, 2021 8:00 AM PDT
        C.E. CREDITS
        APR 01, 2021 8:00 AM PDT
        Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
        NOV 18, 2020 8:00 AM PST
        C.E. CREDITS
        NOV 18, 2020 8:00 AM PST
        DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
        MAR 16, 2021 10:00 AM PDT
        C.E. CREDITS
        MAR 16, 2021 10:00 AM PDT
        Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
        Loading Comments...
        Show Resources
        Attendees
        • See more